News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MAHON PAUL A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/10/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 374 shares
@ $221.9194, valued at
$83k
Sold 2,171 shares
@ $223.3445, valued at
$484.9k
Sold 3,155 shares
@ $224.268, valued at
$707.6k
Sold 300 shares
@ $224.9283, valued at
$67.5k
Exercised 6,000 options
@ $117.76, valued at
$706.6k
|
|
| 10/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/18/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 1,899 shares
@ $227.8117, valued at
$432.6k
Sold 1,400 shares
@ $229.4056, valued at
$321.2k
Sold 1,100 shares
@ $230.2515, valued at
$253.3k
Sold 1,601 shares
@ $231.2343, valued at
$370.2k
Exercised 6,000 options
@ $117.76, valued at
$706.6k
|
|
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/04/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 1,259 shares
@ $232.9592, valued at
$293.3k
Sold 2,141 shares
@ $233.529, valued at
$500k
Sold 600 shares
@ $236.8764, valued at
$142.1k
Sold 300 shares
@ $238.3933, valued at
$71.5k
Sold 400 shares
@ $239.9875, valued at
$96k
Sold 1,000 shares
@ $241.611, valued at
$241.6k
Sold 300 shares
@ $243.13, valued at
$72.9k
Exercised 6,000 options
@ $117.76, valued at
$706.6k
|
|
| 08/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/07/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 3,913 shares
@ $214.5786, valued at
$839.6k
Sold 1,187 shares
@ $215.5178, valued at
$255.8k
Sold 700 shares
@ $217.2366, valued at
$152.1k
Sold 200 shares
@ $218.17, valued at
$43.6k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 07/06/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 3,736 shares
@ $227.5162, valued at
$850k
Sold 2,264 shares
@ $228.1951, valued at
$516.6k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 400 shares
@ $207.01, valued at
$82.8k
Sold 2,750 shares
@ $208.7945, valued at
$574.2k
Sold 2,850 shares
@ $209.7153, valued at
$597.7k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 05/18/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 2,994 shares
@ $214.2674, valued at
$641.5k
Sold 3,006 shares
@ $214.889, valued at
$646k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 05/18/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/17/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 475 shares
@ $211.8663, valued at
$100.6k
Sold 1,277 shares
@ $213.6127, valued at
$272.8k
Sold 2,522 shares
@ $214.5152, valued at
$541k
Sold 1,526 shares
@ $215.3981, valued at
$328.7k
Sold 200 shares
@ $216.0885, valued at
$43.2k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 03/16/2023 |
4/A
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp |
| 03/02/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 600 shares
@ $241.172, valued at
$144.7k
Sold 4,226 shares
@ $242.4535, valued at
$1M
Sold 703 shares
@ $243.2418, valued at
$171k
Sold 471 shares
@ $244.3884, valued at
$115.1k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 1,200 shares
@ $258.4176, valued at
$310.1k
Sold 4,500 shares
@ $259.021, valued at
$1.2M
Sold 300 shares
@ $259.9586, valued at
$78k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 01/05/2023 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 2,200 shares
@ $273.0805, valued at
$600.8k
Sold 3,096 shares
@ $274.1303, valued at
$848.7k
Sold 704 shares
@ $274.759, valued at
$193.4k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 12/16/2022 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 6,000 shares
@ $120.26, valued at
$721.6k
Sold 2,676 shares
@ $271.4353, valued at
$726.4k
Sold 1,924 shares
@ $272.4799, valued at
$524.3k
Sold 800 shares
@ $273.5337, valued at
$218.8k
Sold 517 shares
@ $274.4315, valued at
$141.9k
Sold 83 shares
@ $275.1978, valued at
$22.8k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 12/01/2022 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 729 shares
@ $275.2463, valued at
$200.7k
Sold 800 shares
@ $276.6056, valued at
$221.3k
Sold 2,050 shares
@ $277.6831, valued at
$569.3k
Sold 1,895 shares
@ $278.4563, valued at
$527.7k
Sold 526 shares
@ $279.49, valued at
$147k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 11/17/2022 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 2,102 shares
@ $257.925, valued at
$542.2k
Sold 1,685 shares
@ $258.96, valued at
$436.3k
Sold 1,813 shares
@ $259.9665, valued at
$471.3k
Sold 400 shares
@ $261.1762, valued at
$104.5k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2022 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 2,868 shares
@ $208.9365, valued at
$599.2k
Sold 3,132 shares
@ $209.5565, valued at
$656.3k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 09/26/2022 |
4
| MAHON PAUL A (EVP & GENERAL COUNSEL) has filed a Form 4 on UNITED THERAPEUTICS Corp|
Txns:
| Sold 2,200 shares
@ $202.4638, valued at
$445.4k
Sold 2,300 shares
@ $203.3303, valued at
$467.7k
Sold 1,500 shares
@ $204.645, valued at
$307k
Exercised 6,000 options
@ $120.26, valued at
$721.6k
|
|
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|